Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

por Artene, Stefan-Alexandru, Turcu-Stiolica, Adina, Hartley, Richard, Ciurea, Marius Eugen, Daianu, Oana, Brindusa, Corina, Alexandru, Oana, Tataranu, Ligia Gabriela, Purcaru, Stefana Oana, Dricu, Anica
Publicado 2016